(Q61980882)
Statements
A Single Blind, Open-Label Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of Oral Insulin Formulation in Type 1 Subjects (English)
0 references
July 2008
0 references
August 2008
0 references
12
0 references
18 year
0 references
50 year
0 references